Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2022/09/045264
CTRI/2022/09/045264
Recruiting
Phase 3

Intermediate and long-term therapeutic efficacy of rTMS in drug refractory focalepilepsy of childhood: A Randomized, Double-blind, Sham-Controlled study

ICMRIndia0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: G400- Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: G400- Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset
Sponsor
ICMRIndia
Status
Recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
ICMRIndia

Eligibility Criteria

Inclusion Criteria

  • •1\. Children with more than or equal to 1 seizure per week OR 4 seizures per month despite on more than or equal to 2 appropriately chosen and optimally prescribed antiseizure drugs.
  • •2\. Duration of epilepsy for atleast 1 year
  • •3\. Seizures of single semiology
  • •4\. Majority (75%) of Interictal epileptiform discharges (SWI) arising over a single
  • •epileptogenic focus on sleep EEG
  • •5\. Parents or guardians willing to follow the treatment protocol being followed in the study.
  • •6\.Parents/guardians do not want to undergo epilepsy surgery.
  • •7\. Child is not eligible for epilepsy surgery or Parents/ guardians are un willing to undergo
  • •epilepsy surgery.

Exclusion Criteria

  • •1\. Hemispheric epilepsy syndromes such as Rasmeussen’s encephalitis, Hemiconvulsion\-
  • •hemiplegia epilepsy syndrome or Hemimegalancephaly.
  • •2\. Diagnosed epileptic encephalopathy other than focal ESES (Electrical status epilepticus
  • •in sleep as per standard definition)
  • •3\. Diagnosed progressive neurological disorder
  • •4\. Previous epilepsy surgery or vagal nerve stimulation insertion.
  • •5\. Presence of Metallic implants anywhere in the body.
  • •6\. Epilepsy surgery planned within nine months from the date of enrollment.
  • •Secondary Exclusion Criteria
  • •(To be applied after 4\-week observation period)

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Clinical Audit of chloroquine effect on malaria in children treated in a medical college hospital of Mangalore , Karnataka.Health Condition 1: null- Malaria
CTRI/2016/06/007005Father Muller Medical College Hospital300
Completed
Not Applicable
Evaluation of the effect of tecartherapy on hamstring muscles shortnessShortness of Hamstring Muscle.
IRCT20190920044826N1Tehran University of Medical Sciences30
Recruiting
Not Applicable
A retrospective study on the therapeutic effect of tocilizumab on COVID-19COVID-19
JPRN-UMIN000040614Japanese Red Cross Medical Center20
Completed
Phase 4
Comparing two different desensitizing agents after single application.Health Condition 1: K030- Excessive attrition of teeth
CTRI/2022/01/039577ESWARI PRIYA GUMMADI55
Active, not recruiting
Not Applicable
?The effect of acute and chronic administration of the CCK1 receptor antagonist Dexloxiglumide (CR2017) on 24-h pH metry, LES motor and symptoms? pattern, in patients with gastroesophageal reflux disease (GERD). A randomized, double-blind, placebo controlled study? - NDgastroesaphageal reflux disease (GERD)MedDRA version: 9.1Level: LLTClassification code 10017885Term: Gastrooesophageal reflux disease
EUCTR2007-003478-25-ITROTTAPHARM / ROTTA RESEARCH LABORATORIUM